Table 1.
Age at PRC admission (years) | 52.56 (13.30) |
Sex | |
Female | 60 (61.9%) |
Male | 37 (38.1%) |
Clinical diagnosis of RLS | |
No | 92 (94.8%) |
Yes | 5 (5.2%) |
Duration opioid use (months) | 87.31 (96.27) |
Opioid type | |
Synthetic | 93 (96%) |
Nonsynthetic | 4 (4%) |
MME | 45.59 (48.26) |
MME > 20 | |
No | 36 (37.1%) |
Yes | 61 (62.9%) |
Alpha-2-delta ligand use | |
No | 47 (48.5%) |
Yes | 50 (51.5%) |
Dopamine agonist use | |
No | 92 (94.8%) |
Yes | 5 (5.2%) |
Timepoint taper completed | |
Admission | 5 (5.2%) |
Midpoint | 61 (62.9%) |
Dismissal | 31 (32.0%) |
MME = morphine milligram equivalents, RLS = restless legs syndrome, PRC = Mayo Clinic Pain Rehabilitation Center.